Protective Effect of Minocycline Against Ketamine-Induced Injury in Neural Stem Cell: Involvement of Pi3k/Akt and Gsk-3 Beta Pathway

Yang Lu,Shan Lei,Ning Wang,Pan Lu,Weisong Li,Juan Zheng,Praveen K. Giri,Haixia Lu,Xinlin Chen,Zhiyi Zuo,Yong Liu,Pengbo Zhang
DOI: https://doi.org/10.3389/fnmol.2016.00135
2016-01-01
Frontiers in Molecular Neuroscience
Abstract:It has been suggested that ketamine cause injury during developing brain. Minocycline (MC) could prevent neuronal cell death through the activation of cell survival signals and the inhibition of apoptotic signals in models of neurodegenerative diseases. Here we investigated the protective effect of MC against ketamine-induced injury in neural stem cells (NSCs) from neonatal rat. Ketamine (100 μM/L) significantly inhibited NSC proliferation, promoted their differentiation into astrocytes and suppressed neuronal differentiation of NSCs. Moreover, the apoptotic level was increased following ketamine exposure. MC pretreatment greatly enhanced cell viability, decreased caspase-3-like activity, even reversed the differentiation changes caused by ketamine. To elucidate a possible mechanism of MC’ neuroprotective effect, we investigated the phosphatidylinositol 3-kinase (PI3K) pathway using LY294002, a specific PI3K inhibitor. Immunoblotting revealed that MC enhanced the phosphorylation/activation of Akt and phosphorylation/inactivation of glycogen synthase kinase-3beta (Gsk-3β). Our results suggest that PI3K/Akt and Gsk-3β pathway are involved in the neuroprotective effect of MC.
What problem does this paper attempt to address?